Drugs / EADM
last change Jan 2017 re-read 2 minutes ago

EADM

Developed for
hepatocellular carcinoma

Trials 0

Also used as a comparator or background therapy in 1 trial
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT03048123 Comparator Oct 2015 → Oct 2016 hepatocellular carcinoma Sun Yat-sen University Completed No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as EADM “lipiodol mixed with chemotherapy drugs (EADM, lobaplatin, and MMC)” NCT03048123
Route Other “Hepatic intra-arterial infusion with lipiodol mixed with chemotherapy drugs (EADM, lobaplatin, and MMC)” NCT03048123